Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

NCT02400944

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

NCT05703269

Conditions
Adenocarcinoma, Brain Diseases, Brain Metastases, Adult, +46 more
Locations
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • Crossroads Cancer Center Effingham, Illinois, United States
  • HSHS Saint Elizabeth's Hospital O'Fallon, Illinois, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02845323

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Institute of Urologic Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

NCT04586166

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Florida Robotic and Minimally Invasive Urogynecology Coconut Creek, Florida, United States
  • Augusta University Augusta, Georgia, United States
  • Northwestern Medicine Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05809531

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Academic Medical Research Institute (01034) Los Angeles, California, United States
  • Children's Hospital Colorado (01037) Aurora, Colorado, United States
  • University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States
  • Emory Investigational Drug Service (01021) Atlanta, Georgia, United States
View all 47 locations
View Trial Details

Related conditions